I'm just correlating to the ranked list of most common symptoms. This trial lines up with (improves) the top 7 in the ranked list of symptoms (I put the link in the earlier post). The PR this AM mentioned they saw improvement with Leronlimab in 18 of the symptoms they were looking at and I'm very pleased!
(1)
(1)
CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.